<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl3" position="float"><object-id pub-id-type="doi">10.7554/eLife.25461.010</object-id><label>Table 3.</label><caption><p>Association between kidney disease risk variants and <italic>T.b. gambiense</italic> infection outcome</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.25461.010">http://dx.doi.org/10.7554/eLife.25461.010</ext-link></p><p><supplementary-material id="SD5-data"><object-id pub-id-type="doi">10.7554/eLife.25461.011</object-id><label>Table 3&#8212;source data 1.</label><caption><title><italic>APOL1</italic> genotype data for <italic>T.b. gambiense</italic> clinical stage trypanosomiasis patients and latent carriers</title><p><sup>*</sup>Individuals excluded from the <italic>APOL1</italic> G1 association analysis. <italic>T.b.g: T.b. gambiense</italic>, G0: genotype compatible with the non-risk G0 allele for both rs73885319 and rs60910145, G1: genotype compatible with the G1 CKD risk allele for both rs73885319 and rs60910145, G1<sup>M</sup>: genotype compatible with the G1 CKD risk allele for rs60910145 and the non-risk G0 allele for rs73885319, G1<sup>G</sup>: genotype compatible with the G1 CKD risk allele for rs73885319 and the non-risk G0 allele for rs60910145, G2: genotype compatible with the G2 CKD risk allele for rs71785313.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.25461.011">http://dx.doi.org/10.7554/eLife.25461.011</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-25461-table3-data1-v3.xlsx"/></supplementary-material></p><p><supplementary-material id="SD6-data"><object-id pub-id-type="doi">10.7554/eLife.25461.012</object-id><label>Table 3&#8212;source data 2.</label><caption><title>Association between individual <italic>APOL1</italic> G1 kidney disease risk variants and <italic>T.b. gambiense</italic> infection outcome Two-tailed Fisher's exact test with mid-P method using a dominant genetic model (carriage of 1 or 2 copies of the designated <italic>APOL1</italic> SNP).</title><p>CKD: chronic kidney disease, <italic>T.b.g: T.b. gambiense</italic>, OR: odds ratio, CI: confidence interval. Raw data for <xref ref-type="supplementary-material" rid="SD6-data">Table 3&#8212;source data 2</xref> can be found in <xref ref-type="supplementary-material" rid="SD5-data">Table 3&#8212;source data 1</xref></p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.25461.012">http://dx.doi.org/10.7554/eLife.25461.012</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-25461-table3-data2-v3.xlsx"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="center" colspan="6"><bold>Dominant model &#8211; infection outcome</bold></th></tr><tr><th align="left"><bold><italic>APOL1</italic> haplotype</bold></th><th align="center" colspan="2"><bold><italic>T.b.g</italic> Disease</bold></th><th align="center" colspan="2"><bold><italic>T.b.g</italic> Carriage</bold></th><th align="center" colspan="2"><bold>Association analysis<sup>*</sup></bold> <break/><bold><italic>T.b.g</italic> Disease/Carriage</bold></th></tr><tr><th align="left"/><th align="right">Number</th><th align="right">%</th><th align="right">Number</th><th align="right">%</th><th align="right">OR [95% CI]</th><th align="right"><italic>P</italic></th></tr></thead><tbody><tr><td align="left">G0 Ancestral Haplotype <break/>rs73885319 (A)&#160;+ rs60910145 (T)&#160;+ rs71785313 (TTATAA)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">G0</td><td align="right">144</td><td align="right">86.2</td><td align="right">52</td><td align="right">86.7</td><td align="right">0.96 [0.38 to 2.25]</td><td align="right">0.95</td></tr><tr><td align="left">Non-G0</td><td align="right">23</td><td align="right">13.8</td><td align="right">8</td><td align="right">13.3</td><td align="right"/><td align="right"/></tr><tr><td align="left">Total</td><td align="right">167</td><td align="right">100.0</td><td align="right">60</td><td align="right">100.0</td><td align="right"/><td align="right"/></tr><tr><td align="left">G1 Haplotype<sup>&#8224;&#160;</sup> <break/>rs73885319 (A&gt;G)&#160;+ rs60910145&#160;(T&gt;G)</td><td align="right"/><td align="right"/><td align="right"/><td align="right"/><td align="right"/><td align="right"/></tr><tr><td align="left">G1</td><td align="right">43</td><td align="right">26.7</td><td align="right">30</td><td align="right">52.6</td><td align="right">0.33 [0.17 to 0.62]</td><td align="right">0.0005</td></tr><tr><td align="left">Non-G1</td><td align="right">118</td><td align="right">73.3</td><td align="right">27</td><td align="right">47.4</td><td align="right"/><td align="right"/></tr><tr><td align="left">Total</td><td align="right">161</td><td align="right">100.0</td><td align="right">57</td><td align="right">100.0</td><td align="right"/><td align="right"/></tr><tr><td align="left">G2&#160;Haplotype <break/>rs71785313&#160;(TTATAA&gt;del6)</td><td align="right"/><td align="right"/><td align="right"/><td align="right"/><td align="right"/><td align="right"/></tr><tr><td align="left">G2</td><td align="right">59</td><td align="right">35.3</td><td align="right">9</td><td align="right">15.0</td><td align="right">3.08 [1.45 to 7.06]</td><td align="right">0.0025</td></tr><tr><td align="left">Non-G2</td><td align="right">108</td><td align="right">64.7</td><td align="right">51</td><td align="right">85.0</td><td align="right"/><td align="right"/></tr><tr><td align="left">Total</td><td align="right">167</td><td align="right">100.0</td><td align="right">60</td><td align="right">100.0</td><td align="right"/><td align="right"/></tr></tbody></table><table-wrap-foot><fn id="tblfn5"><p><sup>*</sup>Two-tailed Fisher's exact test with mid-P method using a dominant genetic model (carriage of 1 or 2 copies of the designated <italic>APOL1</italic> haplotype),</p></fn><fn id="tblfn6"><p><sup>&#8224;</sup>Individuals with a partial G1 haplotype were excluded from the analysis. <italic>T.b.g: T.b. gambiense</italic>, OR: odds ratio, CI: confidence interval. Raw data for <xref ref-type="table" rid="tbl3">Table 3</xref> can be found in <xref ref-type="supplementary-material" rid="SD5-data">Table 3&#8212;source data 1</xref>. An association analysis of the two individual component SNPs of the G1 haplotype can be found in <xref ref-type="supplementary-material" rid="SD6-data">Table 3&#8212;source data 2</xref>.</p></fn></table-wrap-foot></table-wrap>